1. Adams, Z. W., Taylor, B. G., Flanagan, E., Kwon, E., Johnson-Kwochka, A. V., Elkington, K. S., Becan, J. E., & Aalsma, M. C. (2021). Opioid Use Disorder Stigma, Discrimination, and Policy Attitudes in a National Sample of U.S. Young Adults. Journal of Adolescent Health, 69(2), 321–328. https://doi.org/10.1016/j.jadohealth.2020.12.142
2. Allport, G. W., (1954). The nature of prejudice. Addison-Wesley
3. Allen, S. T., Ruiz, M. S., & O’Rourke, A. (2015). The evidence does not speak for itself: The role of research evidence in shaping policy change for the implementation of publicly funded syringe exchange programs in three US cities. International Journal of Drug Policy, 26(7), 688-695.
4. Allen, S. T., Grieb, S. M., O’Rourke, A., Yoder, R., Planchet, E., White, R. H., & Sherman,S.G. (2019). Understanding the public health consequences of suspending a rural syringe services program: a qualitative study of the experiences of people who inject drugs. Harm reduction journal, 16(1), 1-10.
5. Bachhuber, M. A., McGinty, E. E., Kennedy-Hendricks, A., Niederdeppe, J., & Barry, C. L. (2015). Messaging to increase public support for naloxone distribution policies in the United States: results from a randomized survey experiment. PloS one, 10(7), e0130050.
6. Baker, L. S., Smith, W., Gulley, T., & Tomann, M. M. (2019). Community Perceptions of Comprehensive Harm Reduction Programs and Stigma Towards People Who Inject Drugs in Rural Virginia. Journal of Community Health, 0123456789. https://doi.org/10.1007/s10900-019-00732-8
7. Baron, R. M., & Kenny, D. A. (1986). The moderator–mediator variable distinction in social psychological research: Conceptual, strategic, and statistical considerations. Journal of personality and social psychology, 51(6), 1173
8. Bonnevie, E., Kaynak, Ö., Whipple, C. R., Kensinger, W. S., Stefanko, M., McKeon, C., Mendell, G & Smyser, J. (2022). Life unites us: A novel approach to addressing opioid use disorder stigma. Health Education Journal, 81(3), 312-324. https://doi.org/10.1177/001789692210774
9. Braun, V., & Clarke, V. (2019). Reflecting on reflexive thematic analysis. Qualitative research in sport, exercise and health, 11(4), 589-597.
10. Braun, V., & Clarke, V. (2021). Conceptual and Design Thinking for Thematic Analysis. Qualitative Psychology, 9(1), 3–26. https://doi.org/10.1037/qup0000196
11. Brener, L., & Von Hippel, W. (2008). Measuring attitudes toward injecting drug users and people with hepatitis C. Substance Use and Misuse, 43(3–4), 295–302.
12. British Irish Council. (2021). COMMUNIQUÉ: Ministerial meeting of the Misuse of
Substances work sector 11 March 2021. https://www.britishirishcouncil.org/sites/default/files/communiqu%C3%A9s/Misuse%20of%20Substances%20Ministerial%20Meeting%20-%20Virtual%20-%2011%20March%202021.pdf
13. Brown, S. A. (2011). Standardized measures for substance use stigma. Drug and
alcohol dependence, 116(1-3), 137-141.
14. Bryan, A., Moran, R., Farrell, E, O’Brien M. (2000). Drug-Related Knowledge, Attitudes and Beliefs in Ireland: Report of a Nation-Wide Survey.[Report] Drug Misuse Research Division, The Health Research Board, Dublin. https://www.lenus.ie/handle/10147/244335
15. Calabrese, C., & Bell, R. A. (2019). Opposition to Nonprescription Naloxone Access: Measurement and Psychosocial Predictors. Substance Use and Misuse, 54(11),
1853– 1861. https://doi.org/10.1080/10826084.2019.1618331
16. Citizens’ Assembly. (2023). Citizens’ Assembly on Drugs Use publishes summary list of 36 recommendations. https://citizensassembly.ie/citizens-assembly-on-drugs-use-publishes-summary-36-recommendations/
17. Cruz, M. F., Patra, J., Fischer, B., Rehm, J., & Kalousek, K. (2007). Public opinion
towards supervised injection facilities and heroin-assisted treatment in Ontario, Canada. International Journal of Drug Policy, 18(1), 54–61. https://doi.org/10.1016/j.drugpo.2006.12.001
18. CityWide. (2016). CityWide: attitude to drugs and drug users. Dublin: CityWide Drug
Crisis Campaign and Red C Research & Marketing. https://www.drugsandalcohol.ie/26840/
19. Corrigan, P., Schomerus, G., Shuman, V., Kraus, D., Perlick, D., Harnish, A., Kulesza, M., Kane-Willis, K., Qin, S., & Smelson, D. (2017). Developing a research agenda for understanding the stigma of addictions Part I: Lessons from the Mental Health Stigma Literature. American Journal on Addictions, 26(1), 59–66 https://doi.org/10.1111/ajad.12458
20. Corrigan, P. W., & Nieweglowski, K. (2019). How does familiarity impact the stigma
of mental illness? Clinical Psychology Review, 70(June 2018), 40–50. https://doi.org/10.1016/j.cpr.2019.02.001
21. Creswell, J.W. & Clark, V.L. (2011). Designing and Conducting Mixed Methods Research. (2nd Edition). Sage Publications.
22. Creswell, J. W. (2021). A concise introduction to mixed methods research. Sage
Publications.
23. Department of Health. (2018). National Strategic Direction for Alcohol and Drugs
Phase 2. Final Review- October 2018. Department of Health, Northern Ireland.
https://www.health-ni.gov.uk/publications/alcohol-and-drug-misuse-strategy and-reports
24. Finke, J., & Chan, J. (2022). The case for supervised injection sites in the United States. American Family Physician, 105(5), 454-455.
25. Hayes, A. F., & Preacher, K. J. (2014). Statistical mediation analysis with a
multicategorical independent variable. British Journal of Mathematical and Statistical Psychology, 67(3), 451–470. https://doi.org/10.1111/bmsp.12028
26. Health Research Board (2023). Health Research Boar reports latest drig-related deaths figures. (Press release).https://www.hrb.ie/news/press-releases/single-press-release/article/health-research-board-reports-latest-drug-related-deaths-figures/
27. Holland, A., Harris, M., Hickman, M., Lewer, D., Shorter, G. W., Horsley, J., ... & Rae, M. (2022). Overdose prevention centres in the UK. The Lancet Public Health, 7(3), e196-e197.https://doi.org/10.1016/S2468-2667(22)00038-X
28. Horvitz-Lennon, M. (2020). Evidence-Based Practices or Practice-Based Evidence: What is the Future?. In: Goldman H., Frank R., Morrissey J. (Eds), The Palgrave Handbook of American Mental Health Policy (pp. 603-638). Palgrave Macmillan, Cham. https://doi.org/10.1007/978-3-030-11908-9_21
29. Igartua, J. J., & Hayes, A. F. (2021). Mediation, moderation, and conditional process analysis: Concepts, computations, and some common confusions. The Spanish Journal of Psychology, 24 (6), e49, 1-23
30. Irwin, A., Jozaghi, E., Bluthenthal, R. N., & Kral, A. H. (2017). A cost-benefit analysis of a potential supervised injection facility in San Francisco, California, USA. Journal of Drug Issues, 47(2), 164-184. https://doi.org/10.1177/002204261667982
31. Kennedy-Hendricks, A., Barry, C. L., Gollust, S. E., Ensminger, M. E., Chisolm, M. S., & McGinty, E. E. (2017). Social stigma toward persons with prescription opioid use disorder: Associations with public support for punitive and public health-oriented policies. Psychiatric Services, 68(5), 462–469. https://doi.org/10.1176/appi.ps.201600056
32. Kenny, A., D. (2021). Mediation. https://davidakenny.net/cm/mediate.htm
33. Kulesza, M., Teachman, B. A., Werntz, A. J., Gasser, M. L., & Lindgren, K. P. (2015). Correlates of public support toward federal funding for harm reduction strategies. Substance Abuse: Treatment, Prevention, and Policy, 10(1), 1–8. https://doi.org/10.1186/s13011-015-0022-5
34. Lemmer, G., & Wagner, U. (2015). Can we really reduce ethnic prejudice outside the lab? A meta‐analysis of direct and indirect contact interventions. European Journal of Social Psychology, 45(2), 152-168.
35. Livingston, J. D., Milne, T., Fang, M. L., & Amari, E. (2012). The effectiveness of interventions for reducing stigma related to substance use disorders: A systematic review. Addiction, 107(1), 39–50. 10.1111/j.1360-0443.2011.03601.x.
36. Lunze, K., Lunze, F. I., Raj, A., & Samet, J. H. (2015). Stigma and human rights abuses against people who inject drugs in Russia—A qualitative investigation to inform policy and public health strategies. PloS one, 10(8), e0136030. https://doi.org/10.1371/journal.pone.0136030
37. McGinty, E., Pescosolido, B., Kennedy-Hendricks, A., & Barry, C. L. (2018). Communication strategies to counter stigma and improve mental illness and substance use disorder policy. Psychiatric Services, 69(2), 136-146. https://doi.org/10.1176/appi.ps.201700076
38. McGinty, E. E., Barry, C. L., Stone, E. M., Niederdeppe, J., Kennedy-Hendricks, A., Linden,S., & Sherman, S. G. (2018). Public support for safe consumption sites and syringe services programs to combat the opioid epidemic. In Preventive Medicine (Vol. 111, Issue January, pp. 73–77). https://doi.org/10.1016/j.ypmed.2018.02.026
39. Miles M. B., Huberman A. M.(1994). Qualitative data analysis: an expanded sourcebook.2nd ed. Sage Publications.
40. Miller,N.M. (2022). Exploration of attitudes towards interventions to reduce opioid drug-related deaths on the island of Ireland and recommendations for social and policy change: a mixed methods inquiry https://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.875613
41. Miller, N. M., Campbell, C., & Shorter, G. W. (2023). Barriers and facilitators of naloxone and safe injection facility interventions to reduce opioid drug-related deaths: A qualitative analysis. International Journal of Drug Policy, 117, 104049. https://doi.org/10.1016/j.drugpo.2023.104049
42. Nieweglowski, K., Corrigan, P. W., Tyas, T., Tooley, A., Dubke, R., Lara, J., Washington, L., Sayer, J., & Sheehan, L. (2017). Exploring the public stigma of substance use disorder through community-based participatory research. Addiction Research and Theory, 26(4), 323–329. https://doi.org/10.1080/16066359.2017.1409890
43. Nieweglowski, K., Dubke, R., Mulfinger, N., Sheehan, L., & Corrigan, P. W. (2019). Understanding the factor structure of the public stigma of substance use disorder. Addiction Research & Theory, 27(2), 156-161.
44. Northern Ireland Statistics and Research Agency. (2022). Drug-related and drug-misuse deaths in Northern Ireland. Statistical bulletin. https://www.nisra.gov.uk/publications/drug-related-and-drug-misuse-deaths-2010-2020
45. Oliver, K., Innvar, S., Lorenc, T., Woodman, J., & Thomas, J. (2014). A systematic review of barriers to and facilitators of the use of evidence by policymakers. BMC health services research, 14(1), 1-12.
46. Office for National Statistics (2022). Deaths related to drug poisoning in England and Wales: 2020 registrations. Deaths related to drug poisoning in England and Wales - Office for National Statistics (ons.gov.uk)
47. Pettigrew, T. F., & Tropp, L. R. (2006). A meta-analytic test of intergroup contact theory. Journal of Personality and Social Psychology, 90(5), 751–783. https://doi.org/10.1037/00223514.90.5.751
48. Phelan, J. C., Link, B. G., & Dovidio, J. F. (2008). Stigma and prejudice: one animal or Public Health Agency two?. Social science & medicine, 67(3), 358-367
49. Randall, N. (2011). Drug policy and rationality: An exploration of the research-policy interface in Ireland. Drugs: Education, Prevention and Policy, 18(4), 285–294. https://doi.org/10.3109/09687637.2010.493540
50. Ritter, A. (2009). How do drug policy makers access research evidence? International Journal of Drug Policy, 20(1), 70–75. https://doi.org/10.1016/j.drugpo.2007.11.017
51. Roberts, K., Dowell, A., & Nie, J. B. (2019). Attempting rigour and replicability in thematic analysis of qualitative research data; A case study of codebook development. BMC Medical Research Methodology, 19(1), 1–8. https://doi.org/10.1186/s12874-019-0707-y
52. Sattler, S., Zolala, F., Baneshi, M. R., Ghasemi, J., & Amirzadeh Googhari, S. (2021). Public Stigma Toward Female and Male Opium and Heroin Users. An Experimental Test of Attribution Theory and the Familiarity Hypothesis. Frontiers in Public Health, 9(April). https://doi.org/10.3389/fpubh.2021.652876
53. Scher, B. D., Neufeld, S. D., Butler, A., Bonn, M., Zakimi, N., Farrell, J., & Greer, A. (2023). “Criminalization Causes the Stigma”: Perspectives From People Who Use Drugs. Contemporary Drug Problems. https://doi.org/10.1177/009145092311792
54. Schuhl, J., Lambert, E., & Chatard, A. (2019) Can Imagination Reduce Prejudice Over Time? A Preregistered Test of the Imagined Contact Hypothesis, Basic and Applied Social Psychology, 41:2, 122-131, DOI: 10.1080/01973533.2019.1579719
55. Shorter, G.W., McKenna-Plumley, P.E., Campbell, K.B.D., Keemink, J.R., Scher, B.D., Cutter, S., Khadjesari, Z., Stevens, A., Artenie, A., Vickerman, P., Boland, P., Miller, N.M., & Campbell, A.O. (2023). Overdose Prevention Centres, Safe Consumption Sites, and Drug Consumption Rooms: A Rapid Evidence Review. Drug Science: London.
56. Singleton, N. (2010). Attitudes to Drug Dependence. Report for the United Kingdom Drug Policy Commission. United Kingdom Drugs Policy Commission: London, UK. Retrieved from: www.ukdpc.org.uk/publications.shtml#Stigma_reports
57. Southwell, M., Scher, B., Harris, M., & Shorter, G. (2022). The case for overdose prevention centres: Voices from Sandwell. Drug Science. DS_Coact-Report_V3_AW.pdf (drugscience.org.uk)
58. Sumnall, H. R., Atkinson, A. M., Trayner, K. M. A., Gage, S. H., & McAuley, A. (2020). Effects of messaging on public support for drug consumption rooms in Scotland, UK. International Journal of Drug Policy, 83, 102855. https://doi.org/10.1016/j.drugpo.2020.102855
59. Sumnall, H. R., Atkinson, A. M., Anderson, M., McAuley, A., & Trayner, K. M. A. (2023). How to save a life: Public awareness of a national mass media take home naloxone campaign, and effects of exposure to campaign components on overdose knowledge and responses. International Journal of Drug Policy, 104111. https://doi.org/10.1016/j.drugpo.2023.104111
60. Taylor, B. G., Lamuda, P. A., Flanagan, E., Watts, E., Pollack, H., & Schneider, J. (2021). Social Stigma toward Persons with Opioid Use Disorder: Results from a Nationally Representative Survey of U.S. Adults. Substance Use & Misuse, 0(0), 1–13. https://doi.org/10.1080/10826084.2021.1949611
61. Tippin, G. K., & Maranzan, K. A. (2022). Photovoice as a method to reduce the stigma ofmental illness among health care students. Health Promotion Practice, 23(2), 331–337. 10.1177/1524839921105715
62. Tostes, J. G. D. A., Dias, R. T., Reis, A. A. D. S., Silveira, P. S. D., & Ronzani, T. M. (2020). Interventions to reduce stigma related to people who use drugs: Systematic review. Paidéia (Ribeirão Preto), 30. 10.1590/1982-4327e3022.
63. Uuskula, A., Des Jarlais, D., & Vorobjov, S. (2019). The fentanyl epidemic in Estonia: opportunities for a comprehensive public health response. The Lancet Psychiatry, 6(12), 985. https://doi.org/10.1016/S2215-0366(19)30436-5
64. Uusküla, A., Talu, A., Vorobjov, S., Salekešin, M., Rannap, J., Lemsalu, L., & Des Jarlais, D. (2020). The fentanyl epidemic in Estonia: factors in its evolution and opportunities for a comprehensive public health response, a scoping review. International Journal of Drug Policy, 81, 102757. https://doi.org/10.1016/j.drugpo.2020.102757
65. Vezzali, Loris, Miles Hewstone, Dora Capozza, Dino Giovannini, and Ralf Wölfer. (2014). Improving intergroup relations with extended and vicarious forms of indirect contact. European review of social psychology 25, no. 1 : 314-389.
66. Vivek, H. P., Singh, S.N., Mishra, S & Donavan, D.T. (2017). Parallel Analysis Engine to Aid in Determining Number of Factors to Retain using R [Computer software], available from https://analytics.gonzaga.edu/parallelengine/.
67. Wild, T. C., Koziel, J., Anderson-Baron, J., Asbridge, M., Belle-Isle, L., Dell, C., Elliot, R., Hathaway, A., MacPherson, D., McBride, K., Pauly, C., Galovan, A.& Hyshka, E. (2021). Public support for harm reduction: A population survey of Canadian adults. PloS one, 16(5), e0251860.